NCT01419457View on ClinicalTrials.gov

Pharmacokinetics of Favipiravir in Volunteers With Hepatic Impairment

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
HealthyHepatic Impairment
Interventions
DRUG

Favipiravir

1200 mg BID for Day 1 + 800 mg BID for Day 2-5

DRUG

Favipiravir

800 mg BID for Day 1 + 400 mg BID for Day 2-3

DRUG

Favipiravir

800 mg Single Dose

Trial Locations (2)

Unknown

University of Miami, Miami

Orlando Clinical Research Center, Orlando

All Listed Sponsors
lead

MDVI, LLC

INDUSTRY

NCT01419457 - Pharmacokinetics of Favipiravir in Volunteers With Hepatic Impairment | Biotech Hunter | Biotech Hunter